Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,413.20 4.66 0.03%
S&P 500 1,864.59 -0.26 -0.01%
NASDAQ 4,095.02 -0.50 -0.01%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences

Webcast Accessible via Sarepta Therapeutics Website

CAMBRIDGE, MA -- (Marketwired) -- 11/19/13 -- Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the following investor conferences in December. Chris Garabedian, Sarepta's president and chief executive officer, will be the presenter.

--  Deutsche Bank BioFEST in Boston, MA on Monday, December 2, 2013 at
    5:10 p.m. Eastern Time.
--  Piper Jaffray 25th Annual Healthcare Conference in New York, NY on
    Wednesday, December 4, 2013 at 9:30 a.m. Eastern Time.

The presentations will be webcast live on the investor relations section of the Sarepta Therapeutics website at and will be archived under the events and presentations section following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at

Sarepta Investor Contact: Erin Cox 857.242.3714

Sarepta Media Contact: Jim Baker 857.242.3710

Sponsored Links
Sponsored Links